Phase I Trial at RAH Meets Safety & Cancer Marker End Points
150723_Phase I Trial at RAH Meets Safety & Cancer Marker End Points
Trading Halt
150722_Trading Halt
First Two Canines Complete Combination Therapy With PPL-1
150716_First Two Canines Complete Combination Therapy With PPL-1
Appendix 4G & Corporate Governance Statement
150828_Appendix 4G & Corporate Governance Statement
Appendix 4E & Full Year Statutory Accounts
150828_Appendix 4E & Full Year Statutory Accounts
Appendix 4C – Quarterly Report & Company Update
150728_Appendix 4C – Quarterly Report & Company Update
PharmAust Receives ATO Research & Development Rebate
150624_PharmAust Receives ATO Research & Development Rebate
PharmAust Initiates Combination Therapy Evaluations in Dogs
150617_PharmAust Initiates Combination Therapy Evaluations in Dogs
Epichem Successful in AusTrade Grant
160616_ Epichem Successful in AusTrade Grant
Change of registry address
150612_Change of registry address